Outsourcing-Pharma

Can't read the email below? Click Here

Today on Outsourcing-Pharma.com

>	Overcoming intellectual property phobia in China
>	A world of outsourcing awaits - Part II clinical research
>	A world of outsourcing awaits - part III drug manufacturing
>	FDA to review electronic signature regulation
>	Clinphone heads down under

Other top industry news

>	Dry-powder inhaler 'revolution' unveiled
>	Big pharma business model needs to change
>	DSM accelerates anti-infective activity
>	Researchers discover sugar compound wards off seizures

	Outsourcing Pharma

Search Forward to a colleague		Wednesday 25 October 2006

Sponsored by Cardinal Health
Cardinal Health enhances drug delivery
Cardinal Health is a world leader in patented drug-delivery technologies. We develop and manufacture advanced drug-delivery systems and partner with nearly every major global pharmaceutical company. Click Here

Access full stories

Overcoming intellectual property phobia in China
China is a big market with a lot of potential but many pharma industry firms still avoid doing business in the country because of "mistaken" fears that their intellectual property (IP) cannot be protected... Read

A world of outsourcing awaits - Part II clinical research
Pharma companies that aren't maximising their outsourcing potential in clinical research may be wasting a world of opportunity. OutsourcingPharma.com gives a brief run down of exactly what kinds of services and... Read

A world of outsourcing awaits - part III drug manufacturing
Although manufacturing is the most established of the pharma outsourcing segments, many service areas are still rapidly evolving. OutsourcingPharma.com gives a brief run down of the current state of play... Read

FDA to review electronic signature regulation
The FDA is expected to issue a revised version of its regulation on electronic signatures and records by the end of the year, which will force drug and device companies to reconsider their current information management... Read

Clinphone heads down under
As the Asia-Pacific continues to be a hotspot for clinical trials activity, e-clinical provider ClinPhone has opened its first office in the region in the hope of gaining a head start... Read

All News Headlines for: October | September | August

Sponsored by SF-Chem
High-quality intermediates
SF-Chem is a supplier of high-quality intermediates to customers in the global chemical industry, particularly pharmaceuticals. The company is highly specialised in chlorine and sulfur chemistry. Click Here

Previous Headlines

>	PPD Q3 profit increases, boost ...

>	MDS Pharma opens first US cent ...

>	A world of outsourcing awaits ...

>	Contamination risks challenge ...

>	US and EU pharma trade bodies ...

>	Covance adopts unique in-vitro ...

>	PDI faces another major contra ...

>	Quintiles steps up Indian pres ...

>	Morocco vying for clinical tri ...

>	Saltigo expands capacity as fi ...

Product Categories

>	Product & Supplier News - Contract Manufacturing

Related Web Sites

>	In-PharmaTechnologist.com

>	DrugResearcher.com

>	BioPharmaReporter.com



>	All our Websites

Other top industry news

Dry-powder inhaler 'revolution' unveiled
A new dry powder inhaler that may cost less than a syringe and deliver 40 per cent more active drug than current inhalers has been unveiled by its maker, Cambridge Consultants... Read

Big pharma business model needs to change
The current big pharma business model is not sustainable for the future and will need to change, delegates heard at the recent Financial Times (FT) global Pharmaceuticals and Biotechnology Conference... Read

DSM accelerates anti-infective activity
Using a processing technique described as "revolutionary," DSM is accelerating up its activity in the anti-infective arena and targeting new active pharmaceutical ingredients (APIs) that it can develop into cost-competitive... Read

Researchers discover sugar compound wards off seizures
A new compound has the potential to effectively cure epilepsy, raising hopes that a new drug can be produced to treat epileptic patients... Read

Events - Publisher's Choice

STAY up-to-date with pharmaceutical Innovations
Visit our regularly updated events calendar and learn about important events within the industry today ... Read

ELNS & Laboratory Informatics
4 days of interactive sessions and case studies providing the most current assessment of the future of electronic data recording implementation, integ ... Read

Sponsored by Cardinal Health
Comprehensive Pulmonary & Nasal Dosage Forms
Cardinal Health offers comprehensive pulmonary and nasal development services to take your product from concept and feasibility studies through regulatory approval and commercial-scale manufacturing. Click Here

Forward to a colleague

Subscribe to other Decision News Media e-newsletters - Pharmaceuticals

	To continue to receive this newsletter in your inbox, please add newsletter@outsourcing-pharma.com to your address book
	Update preferences \| Change your email address \| ***
	Contact us: Advertising \| Recruitment \| Privacy policy \| Terms & conditions \| Feedback
	© 2006 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com

Back to newsletter list

Date:

From:

Subject:

25/10 China IP/contract research/contract manufacturing/electronic signature/e-Clinical